These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 31370214)

  • 1. The Finnish New Variant of
    Hokynar K; Rantakokko-Jalava K; Hakanen A; Havana M; Mannonen L; Jokela P; Kurkela S; Lappalainen M; Unemo M; Puolakkainen M
    Microorganisms; 2019 Jul; 7(8):. PubMed ID: 31370214
    [TBL] [Abstract][Full Text] [Related]  

  • 2. No widespread dissemination of
    Cole MJ; Davis GS; Fifer H; Saunders JM; Unemo M; Hadad R; Roberts DJ; Fazal M; Day MJ; Minshull J; Muir P; Horner PJ; Gill NO; Folkard K
    Sex Transm Infect; 2022 Aug; 98(5):366-370. PubMed ID: 34510008
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Chlamydia trachomatis 23S rRNA G1523A variant escaping detection in the Aptima Combo 2 assay (Hologic) was widespread across Denmark in July-September 2019.
    Hadad R; Jensen JS; Westh H; Grønbaek I; Schwartz LJ; Nielsen L; Vang TM; Nielsen R; Weinreich LS; Skov MN; Olsen M; Møller JK; Kolmos B; Unemo M; Hoffmann S
    APMIS; 2020 Jun; 128(6):440-444. PubMed ID: 32202687
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chlamydia trachomatis Variants Escaping Detection in the Aptima Combo 2 Assay in the United States.
    Katz SS; Danavall DC; Morris MR; Herrod BP; Dale SE; Nye MB; Kersh EN; Kirkcaldy RD; Raphael BH
    Sex Transm Dis; 2022 Jun; 49(6):448-452. PubMed ID: 35171128
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sensitivity, specificity, inclusivity and exclusivity of the updated Aptima Combo 2 assay, which provides detection coverage of the new diagnostic-escape Chlamydia trachomatis variants.
    Unemo M; Hansen M; Hadad R; Puolakkainen M; Westh H; Rantakokko-Jalava K; Thilesen C; Cole MJ; Boiko I; Lan PT; Golparian D; Ito S; Sundqvist M
    BMC Infect Dis; 2020 Jun; 20(1):419. PubMed ID: 32546213
    [TBL] [Abstract][Full Text] [Related]  

  • 6.
    Rantakokko-Jalava K; Hokynar K; Hieta N; Keskitalo A; Jokela P; Muotiala A; Jokiranta TS; Kuusela R; Sarkkinen H; Aittoniemi J; Vuorinen T; Hakanen AJ; Puolakkainen M
    Euro Surveill; 2019 May; 24(22):. PubMed ID: 31164192
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Finnish new variant of
    Unemo M; Hansen M; Hadad R; Lindroth Y; Fredlund H; Puolakkainen M; Sundqvist M
    Euro Surveill; 2019 Jun; 24(26):. PubMed ID: 31266590
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the APTIMA CT and GC assays with the APTIMA combo 2 assay, the Abbott LCx assay, and direct fluorescent-antibody and culture assays for detection of Chlamydia trachomatis and Neisseria gonorrhoeae.
    Boyadzhyan B; Yashina T; Yatabe JH; Patnaik M; Hill CS
    J Clin Microbiol; 2004 Jul; 42(7):3089-93. PubMed ID: 15243065
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The 'Finnish new variant of
    Johansen TB; Kløvstad H; Rykkvin R; Herrfurth-Erichsen EB; Sorthe J; Njølstad G; Ebbesen MH; Nygaard RM; Sandmoen EK; Thilesen C; Onken A; Liljedal I; Hadad R; Unemo M
    Euro Surveill; 2019 Oct; 24(42):. PubMed ID: 31640843
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of new variants of
    Roberts DJ; Davis GS; Cole MJ; Naik D; Maru H; Woodford N; Muir P; Horner P; Simms I; Thickett G; Crook P; Foster K; Andrews N; Saunders J; Fifer H; Folkard K; Gill ON;
    Euro Surveill; 2019 Sep; 24(38):. PubMed ID: 31552817
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of Gen-probe transcription-mediated amplification, Abbott PCR, and Roche PCR assays for detection of wild-type and mutant plasmid strains of Chlamydia trachomatis in Sweden.
    Møller JK; Pedersen LN; Persson K
    J Clin Microbiol; 2008 Dec; 46(12):3892-5. PubMed ID: 18842934
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The verification of nucleic acid amplification testing (Gen-Probe Aptima Assay) for chlamydia trachomatis from ocular samples.
    Kowalski RP; Karenchak LM; Raju LV; Ismail N
    Ophthalmology; 2015 Feb; 122(2):244-7. PubMed ID: 25439605
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Specimen processing and concentration of Chlamydia trachomatis added can influence false-negative rates in the LCx assay but not in the APTIMA Combo 2 assay when testing for inhibitors.
    Chong S; Jang D; Song X; Mahony J; Petrich A; Barriga P; Chernesky M
    J Clin Microbiol; 2003 Feb; 41(2):778-82. PubMed ID: 12574282
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of Chlamydia trachomatis by nucleic acid amplification testing: our evaluation suggests that CDC-recommended approaches for confirmatory testing are ill-advised.
    Schachter J; Chow JM; Howard H; Bolan G; Moncada J
    J Clin Microbiol; 2006 Jul; 44(7):2512-7. PubMed ID: 16825373
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A molecular screening assay to identify Chlamydia trachomatis and distinguish new variants of C. trachomatis from wild-type.
    Xiu L; Li Y; Zhang C; Li Y; Zeng Y; Wang F; Peng J
    Microb Biotechnol; 2021 Mar; 14(2):668-676. PubMed ID: 33277967
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of urine testing in evaluations of the sensitivity of the Gen-Probe Aptima Combo 2 assay on endocervical swabs for Chlamydia trachomatis and neisseria gonorrhoeae: the infected patient standard reduces sensitivity of single site evaluation.
    Moncada J; Schachter J; Hook EW; Ferrero D; Gaydos C; Quinn TC; Willis D; Weissfeld A; Martin DH
    Sex Transm Dis; 2004 May; 31(5):273-7. PubMed ID: 15107628
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High analytical sensitivity and low rates of inhibition may contribute to detection of Chlamydia trachomatis in significantly more women by the APTIMA Combo 2 assay.
    Chernesky M; Jang D; Luinstra K; Chong S; Smieja M; Cai W; Hayhoe B; Portillo E; Macritchie C; Main C; Ewert R
    J Clin Microbiol; 2006 Feb; 44(2):400-5. PubMed ID: 16455891
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Abilities of APTIMA, AMPLICOR, and ProbeTec assays to detect Chlamydia trachomatis and Neisseria gonorrhoeae in PreservCyt ThinPrep Liquid-based Pap samples.
    Chernesky M; Jang D; Portillo E; Chong S; Smieja M; Luinstra K; Petrich A; Macritchie C; Ewert R; Hayhoe B; Sarabia A; Thompson F
    J Clin Microbiol; 2007 Aug; 45(8):2355-8. PubMed ID: 17537943
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of Chlamydia trachomatis and Neisseria gonorrhoeae infections in North American women by testing SurePath liquid-based Pap specimens in APTIMA assays.
    Chernesky M; Freund GG; Hook E; Leone P; D'Ascoli P; Martens M
    J Clin Microbiol; 2007 Aug; 45(8):2434-8. PubMed ID: 17581931
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of Neisseria gonorrhoeae and Chlamydia trachomatis in pharyngeal and rectal specimens using the BD Probetec ET system, the Gen-Probe Aptima Combo 2 assay and culture.
    Ota KV; Tamari IE; Smieja M; Jamieson F; Jones KE; Towns L; Juzkiw J; Richardson SE
    Sex Transm Infect; 2009 Jun; 85(3):182-6. PubMed ID: 19126571
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.